382 related articles for article (PubMed ID: 19199030)
1. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice.
Takeda T
Neurochem Res; 2009 Apr; 34(4):639-59. PubMed ID: 19199030
[TBL] [Abstract][Full Text] [Related]
2. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research.
Takeda T
Neurobiol Aging; 1999; 20(2):105-10. PubMed ID: 10537019
[TBL] [Abstract][Full Text] [Related]
3. [Senescence-accelerated mouse (SAM): with special reference to age-associated pathologies and their modulation].
Takeda T
Nihon Eiseigaku Zasshi; 1996 Jul; 51(2):569-78. PubMed ID: 8783874
[TBL] [Abstract][Full Text] [Related]
4. Senescence-accelerated mouse (SAM): a novel murine model of senescence.
Takeda T; Hosokawa M; Higuchi K
Exp Gerontol; 1997; 32(1-2):105-9. PubMed ID: 9088907
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10.
Miyamoto M
Exp Gerontol; 1997; 32(1-2):139-48. PubMed ID: 9088911
[TBL] [Abstract][Full Text] [Related]
6. Alterations in local thyroid hormone signaling in the hippocampus of the SAMP8 mouse at younger ages: association with delayed myelination and behavioral abnormalities.
Sawano E; Negishi T; Aoki T; Murakami M; Tashiro T
J Neurosci Res; 2013 Mar; 91(3):382-92. PubMed ID: 23224839
[TBL] [Abstract][Full Text] [Related]
7. Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biological approach.
Okuma Y; Nomura Y
Jpn J Pharmacol; 1998 Dec; 78(4):399-404. PubMed ID: 9920195
[TBL] [Abstract][Full Text] [Related]
8. The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model.
Chiba Y; Shimada A; Kumagai N; Yoshikawa K; Ishii S; Furukawa A; Takei S; Sakura M; Kawamura N; Hosokawa M
Neurochem Res; 2009 Apr; 34(4):679-87. PubMed ID: 18688709
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes.
Tanisawa K; Mikami E; Fuku N; Honda Y; Honda S; Ohsawa I; Ito M; Endo S; Ihara K; Ohno K; Kishimoto Y; Ishigami A; Maruyama N; Sawabe M; Iseki H; Okazaki Y; Hasegawa-Ishii S; Takei S; Shimada A; Hosokawa M; Mori M; Higuchi K; Takeda T; Higuchi M; Tanaka M
BMC Genomics; 2013 Apr; 14():248. PubMed ID: 23586671
[TBL] [Abstract][Full Text] [Related]
10. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease.
Butterfield DA; Poon HF
Exp Gerontol; 2005 Oct; 40(10):774-83. PubMed ID: 16026957
[TBL] [Abstract][Full Text] [Related]
11. Differences in saccharin preference and genetic alterations of the Tas1r3 gene among senescence-accelerated mouse strains and their parental AKR/J strain.
Niimi K; Takahashi E
Physiol Behav; 2014 May; 130():108-12. PubMed ID: 24726396
[TBL] [Abstract][Full Text] [Related]
12. [Effects of melatonin in the brain of the senescence-accelerated mice-prone 8 (SAMP8) model].
Gutierrez-Cuesta J; Tajes M; Jimenez A; Camins A; Pallas M
Rev Neurol; 2011 May; 52(10):618-22. PubMed ID: 21488009
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological studies on strains of senescence-accelerated mice (SAM) with age-related deficits in learning and memory.
Kawamata T; Akiguchi I; Yagi H; Irino M; Sugiyama H; Akiyama H; Shimada A; Takemura M; Ueno M; Kitabayashi T; Ohnishi K; Seriu N; Higuchi K; Hosokawa M; Takeda T
Exp Gerontol; 1997; 32(1-2):161-9. PubMed ID: 9088913
[TBL] [Abstract][Full Text] [Related]
14. Assessment of social interaction and anxiety-like behavior in senescence-accelerated-prone and -resistant mice.
Meeker HC; Chadman KK; Heaney AT; Carp RI
Physiol Behav; 2013 Jun; 118():97-102. PubMed ID: 23672852
[TBL] [Abstract][Full Text] [Related]
15. Early onset of behavioral alterations in senescence-accelerated mouse prone 8 (SAMP8).
Yanai S; Endo S
Behav Brain Res; 2016 Jul; 308():187-95. PubMed ID: 27093926
[TBL] [Abstract][Full Text] [Related]
16. Depressive behavior and alterations in receptors for dopamine and 5-hydroxytryptamine in the brain of the senescence accelerated mouse (SAM)-P10.
Onodera T; Watanabe R; Tha KK; Hayashi Y; Murayama T; Okuma Y; Ono C; Oketani Y; Hosokawa M; Nomura Y
Jpn J Pharmacol; 2000 Aug; 83(4):312-8. PubMed ID: 11001177
[TBL] [Abstract][Full Text] [Related]
17. Characterization of senescence-accelerated mouse prone 6 (SAMP6) as an animal model for brain research.
Niimi K; Takahashi E
Exp Anim; 2014; 63(1):1-9. PubMed ID: 24521858
[TBL] [Abstract][Full Text] [Related]
18. [Anti-aging studies on the senescence accelerated mouse (SAM) strains].
Takahashi R
Yakugaku Zasshi; 2010 Jan; 130(1):11-8. PubMed ID: 20046059
[TBL] [Abstract][Full Text] [Related]
19. Age-related alterations in the expression of glial cell line-derived neurotrophic factor in the senescence-accelerated mouse brain.
Miyazaki H; Okuma Y; Nomura J; Nagashima K; Nomura Y
J Pharmacol Sci; 2003 May; 92(1):28-34. PubMed ID: 12832852
[TBL] [Abstract][Full Text] [Related]
20. Genetic characterization of senescence-accelerated mouse (SAM).
Higuchi K
Exp Gerontol; 1997; 32(1-2):129-38. PubMed ID: 9088910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
